Karachi: Trust Securities & Brokerage Limited (TSBL) has successfully completed the subscription process for its Rights Shares issue, with the full subscription amount of PKR 450.00 million duly received. The announcement was made on March 25, 2026, following the confirmation from the company’s auditors regarding the receipt of the entire amount.

According to the official correspondence addressed to the Pakistan Stock Exchange (PSX) and the Central Depository Company of Pakistan Limited (CDC), the subscription comprised 450 million Right Shares, each valued at Re. 1. The company’s management has submitted a request for the issuance of a No Objection Certificate (NOC) to facilitate the release of the subscription funds in favor of JS Bank Limited, which acted as the Banker to the Issue.

The auditor’s certificate, which serves as a crucial requirement by the PSX and CDC, confirms the successful collection of the subscription amount. The subscription process included contributions from directors, substantial shareholders, sponsors, and general shareholders through designated bank accounts and the CDC’s online payment option. Specifically, Rs. 385.50 million was collected through bank deposits, while Rs. 64.50 million was received via online payments.

According to information available from the Pakistan Stock Exchange (PSX), the paid-up capital of TSBL has now increased from PKR 300.00 million to PKR 750.00 million following the rights issue. The move is expected to strengthen the company’s capital structure and support its future growth initiatives.

The company has adhered to all regulatory requirements set forth under the Companies Act, 2017, and the relevant guidelines from the Securities and Exchange Commission of Pakistan. No additional conditions have been imposed by regulatory authorities at this stage, ensuring a smooth transition in the company’s capital restructuring efforts.

This development places TSBL in a favorable position within the market, as it fulfills the compliance requirements necessary for the allotment of shares under the CDC’s regulations, further cementing its standing in the designated market category.